See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0000810509_2020_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc.
| |
xvar |
xval |
| 0 |
LiabilitiesNoncurrent |
512,344 |
| 1 |
LiabilitiesCurrent |
3,819,551 |
| 2 |
remainder_Liabilities |
700,000 |
| 3 |
AssetsCurrent |
2,915,783 |
| 4 |
AssetsNoncurrent |
819,500 |
| 5 |
PropertyPlantAndEquipmentNet |
30,210 |
| 6 |
Goodwill |
385,413 |
| 7 |
remainder_Assets |
0 |
| 8 |
GeneralAndAdministrativeExpense |
6,282,076 |
| 9 |
ResearchAndDevelopmentExpense |
5,338,267 |
| 10 |
remainder_Expenses |
707 |
| 11 |
remainder_Revenues |
657,826 |
| 12 |
remainder_NetIncome |
15,010 |
| 13 |
remainder_ComprehensiveNetIncome |
730 |
| |
yvar |
yval |
| 0 |
Liabilities |
5,031,895 |
| 1 |
Assets |
4,150,906 |
| 2 |
Expenses |
11,621,050 |
| 3 |
Revenues |
657,826 |
| 4 |
StockholdersEquity |
-880,989 |
| 5 |
NetIncome |
-10,948,214 |
| 6 |
ComprehensiveNetIncome |
-10,947,849 |
| 7 |
BaseVar |
10,738,708 |
| 8 |
EconomicCapitalRatio |
-2.55 |
Edgar->Model Mapping
Feature Distribution
Change over Time
